How should we measure informed choice? The case of cancer screening.
about
Personalised risk communication for informed decision making about taking screening testsPersonalised risk communication for informed decision making about taking screening testsCommon methods of measuring 'informed choice' in screening participation: Challenges and future directionsMethods to increase participation in organised screening programs: a systematic review.The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.Client and practitioner perspectives on the screening mammography experience.Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid.Informed choice for screening: implications for evaluation.Measuring informed choice in population-based reproductive genetic screening: a systematic review.Financial incentives for increasing uptake of HPV vaccinations: a randomized controlled trialThe role of communication in breast cancer screening: a qualitative study with Australian experts.Eliciting women's cervical screening preferences: a mixed methods systematic review protocolEthnic minority women prefer strong recommendations to be screened for cancerPreferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment.Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation.An Individualized Approach to Cancer Screening Decisions in Older Adults: A Multilevel Framework.Public perceptions of communicating information about bowel cancer screening.Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.Uptake in cancer screening programmes: a priority in cancer control.Health literacy and informed decision making regarding colorectal cancer screening: a systematic review.Informed choice about Down syndrome screening - effect of an eHealth tool: a randomized controlled trial.Uninformed compliance or informed choice? A needed shift in our approach to cancer screening.Social representations of human papillomavirus in Bogotá, Colombia.'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.A comparison of face to face and group education on informed choice and decisional conflict of pregnant women about screening tests of fetal abnormalities.Informing Women and Their Physicians about Recommendations for Adjunct Breast MRI Screening: A Cohort Study.It's hard to reach the "hard-to-reach": the challenges of recruiting people who do not access preventative healthcare services into interview studiesA qualitative study exploring why people do not participate in cardiac rehabilitation and coronary heart disease self-help groups, and their rehabilitation experience without these resources
P2860
Q24200761-23E8CBD8-8FB9-4229-9234-65C57A2F36BEQ24244218-30A407CE-3A60-4662-AB16-5BB0751AA162Q28069573-47C685B5-0183-4BD8-84D2-35839264268DQ30540772-872ED1E6-6393-42F9-A835-49426190A787Q30578410-CE0E175A-2A0A-4C6F-AF4F-ACDB571B2FE8Q33605457-CA2339EF-9D9A-4F24-BB65-D8F6E4D6FD97Q33834179-B8EBD817-84A2-46E3-BF41-668B697CBBDCQ34264806-92E50591-614F-45E9-9D91-50F23E1BED9DQ34601338-B53207F5-51AA-41C3-BADD-5CEA30B25EADQ34705206-EC8D2A6A-1321-4D19-BD89-248CBCF95A47Q35032369-FBE86F78-CA50-4ADB-8B2B-09C3D25CE2B2Q35813074-3C9CE898-4191-4DDF-A805-72249326B8BAQ36102272-116C6395-5AA1-41B3-9141-DF609D318F69Q36270318-405F5BDF-4B58-49EC-8D49-E1F9A2A0F291Q36304311-CEE2E336-742F-4297-A96B-39AB5C53F196Q36451775-577F3FE2-E48E-4680-B0BD-90CF8BDEC4ACQ36809001-84F029C9-3E2A-4B87-A9B5-46543A05C42AQ37332172-E90888F2-9D65-4E19-8B8E-10B2DA0575E7Q37333195-438E866A-B64F-4EFD-9023-282FE8325FCFQ37466638-8C436D40-01D5-478D-BC0E-56B1291EB26FQ38367087-2ACC3156-2707-4FDD-9B06-E8F2AD86AF75Q40581842-AA27B76B-8573-4C61-B567-CDBDAB853840Q45136794-117B5636-1A7A-4837-8B06-3E51CCC13066Q47230014-527956F4-AE81-43C8-9414-B360F35FB251Q48233913-09C5EFB9-141A-4E36-B41C-CF569AE159E7Q49606166-0C60297A-F9E3-47C3-82DE-FC158F9BA63BQ50914124-4EEF6B3D-9B2F-47CB-B757-9919EAFC3ED5Q57126514-57A5B679-CE02-45A6-AC5B-A23250CD8366Q57851189-CB751240-D3FB-4CD7-9194-D148ECB0B5CA
P2860
How should we measure informed choice? The case of cancer screening.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
How should we measure informed choice? The case of cancer screening.
@ast
How should we measure informed choice? The case of cancer screening.
@en
type
label
How should we measure informed choice? The case of cancer screening.
@ast
How should we measure informed choice? The case of cancer screening.
@en
prefLabel
How should we measure informed choice? The case of cancer screening.
@ast
How should we measure informed choice? The case of cancer screening.
@en
P2093
P2860
P356
P1476
How should we measure informed choice? The case of cancer screening.
@en
P2093
P2860
P304
P356
10.1136/JME.2003.005793
P577
2005-04-01T00:00:00Z